Biotechnology News

July 14, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced top-line results from a Phase 2b monotherapy clinical trial of TC-1734 as a...

July 14, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Zycus has demonstrated a strong capability and deep expertise for rapidly and accurately classifying, enriching and transforming ERP and other spend transaction data into procurement-centric views.

July 14, 2014

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics has acquired rights to new technologies developed at Washington University School of Medicine to commercialize a clinical blood test for detection of early Alzheimer's Disease.

July 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ: XLRN) appoints Terrence C. Kearney to its Board of Directors and to the position of Chair of the Audit Committee.

July 14, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth Hires Medical Director for U.S. Next-Gen Sequencing Lab

July 14, 2014

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation has announced a product development agreement with Mellitus LLC of Cambridge, Mass., involving the development of a new in vitro diagnostic test for gestational diabetes.

July 14, 2014

NEW YORK--(BUSINESS WIRE)--BIOTECHNOLOGY ANALYST BORIS PEAKER JOINS COWEN’S EQUITY RESEARCH DEPARTMENT

July 14, 2014

SAN DIEGO--(BUSINESS WIRE)--DermTech Publishes Clinical Data in the Journal of American Academy of Dermatology

July 14, 2014

ST. PAUL, Minn. & WILMINGTON, Mass.--(BUSINESS WIRE)--St. Jude Medical announces a definitive agreement to acquire NeuroTherm. The acquisition is expected to accelerate growth of St. Jude Medical’s chronic pain business.

July 14, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) announced today the issuance of 14 new patents to BioTime and its subsidiary companies. The patents issued in Australia, Canada, China, Japan, and the United States, cover a wide...

July 14, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Trevi Therapeutics initiates pivotal study of Nalbuphine ER in uremic pruritus.

July 14, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA’s biopharmaceutical division today announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014.

July 14, 2014

NEW YORK--(BUSINESS WIRE)--BTIG LLC, a global financial services firm specializing in institutional trading and related brokerage services, announced that Hartaj Singh has joined the firm as a Director and Biotechnology Analyst

July 14, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on July 11, 2014, the Company’s issued share capital, excluding...

July 14, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that it has filed an investor presentation with the Securities and Exchange Commission (“SEC”) and posted the presentation under the “...

July 14, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, July 31, 2014. The schedule for the press release...

July 14, 2014

SAN DIEGO--(BUSINESS WIRE)--Results of a health economics study in the Journal of Medical Economics found that use of bioTheranostics’ CancerTYPE ID® molecular test is a cost-effective approach to patient care.

July 14, 2014

JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, has issued a letter to...

July 14, 2014

BROOKLINE, Mass.--(BUSINESS WIRE)--Transplant Genomics Inc. has licensed patent rights from The Scripps Research Institute and Northwestern University that provide the foundation for clinical tests to improve management of transplants.

July 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea has commenced an underwritten public offering of 3,400,000 shares of its common stock.

July 14, 2014

RALEIGH, N.C. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) today announced that the Food and Drug Administration (FDA or Agency) has informed Salix that RELISTOR® (...

July 14, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Extends Discovery Capabilities to Additional Immunomodulatory Proteins, leads to predictive discovery of 4 potential immunomodulatory targets; New candidates enter Company’s Pipeline Program

July 14, 2014

SHANGHAI & DUESSELDORF, Germany--(BUSINESS WIRE)--miacom diagnostics GmbH teams up with Fosun Diagnostics, a Diagnostic Division of Shanghai Fosun Pharmaceutical Group

July 14, 2014

WORCESTER, Mass.--(BUSINESS WIRE)--VitaThreads LLC today reported that the VitaSuture Wound Management Systems (VWMS) met a primary endpoint of incisional closure and secondary histological endpoints in pre-clinical in vivo animal studies. The...

July 14, 2014

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Reaches Halfway Mark for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation

July 14, 2014

BRAINTREE, Mass.--(BUSINESS WIRE)--Paragonix Technologies Inc., Announces Filing of a 510(k) Pre-Market Notification with the US Food and Drug Administration for the Paragonix Sherpa Perfusion™ Cardiac Transport System.

July 14, 2014

MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that it has received clearance from the U.S. Food and Drug Administration (...

July 14, 2014

TOKYO & COPENHAGEN, Denmark--(BUSINESS WIRE)--Otsuka and Lundbeck submit NDA in US for brexpiprazole for treatment of schizophrenia and as adjunctive therapy for treatment of major depressive disorder

July 14, 2014

MANCHESTER, England--(BUSINESS WIRE)--Cytox, a leading developer of assays for risk assessment and prediction of dementia, announced the timing of a presentation discussing the development of a novel proprietary blood-based assay for the...

July 14, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced positive top-line results from coBRIM, the phase 3 pivotal trial evaluating cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination...

July 14, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III coBRIM study met its primary endpoint. The study demonstrated that the investigational MEK...

July 11, 2014

NEWARK, Calif.--(BUSINESS WIRE)--Maxygen, Inc. announced today that it has revised the previously announced record date for its final liquidating distribution in the amount of $0.093 per share of common stock from August 29, 2013 to June 29, 2014...

July 11, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today provided the following comment in response to the definitive proxy solicitation filed by Pershing Square Capital Management, L.P. (“Pershing Square”)...

July 11, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Tuesday, August 5, 2014, at 3:30 p.m. Central Time to discuss the Company’s operating results for its second quarter...

July 11, 2014

PARIS--(BUSINESS WIRE)--France Biotech, (www.france-biotech.org), an association of entrepreneurs in the life sciences industry, today announced the high level of interest...

July 11, 2014

PARIS--(BUSINESS WIRE)--The 25th annual Neuronal Plasticity Prize of the Fondation Ipsen has been awarded to three researchers for their pioneer works in the domain of “Neuropsychology of drug addiction”: Barry J. Everitt (University of Cambridge...

July 11, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT: XXII) announced that it has engaged a major contract research organization for the Company’s potentially less harmful cigarettes at the FDA.

July 11, 2014

--(BUSINESS WIRE)--BiOM is the leader in the field of personal bionics with the introduction of the first powered prosthetic device, BiOM T2. Privately held and headquartered in Bedford, Mass., BiOM was founded in 2007 by Dr. Hugh Herr, Director...

July 11, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI presents Rheumatoid Arthritis data at 12th Vaccines Research & Development conference.

July 11, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna to ring NASDAQ closing bell on 7/15

July 11, 2014

OTTAWA, Canada--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced that on July 10, 2014 the Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act...